Yanmaz Muyesser Nergiz, Özcan Ayşet Jane, Savan Kadir
Istanbul Kemerburgaz University School of Medicine, Internal Medicine and Rheumatology, Medicalpark Hospital, Kültür sok No. 1, 34160, Istanbul, Turkey,
Clin Rheumatol. 2014;33(10):1385-8. doi: 10.1007/s10067-014-2709-9. Epub 2014 Jun 14.
Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by recurrent attacks of fever, peritonitis, pleuritis, arthritis, or erysipelas-like skin lesion. FMF is the most common periodic febrile syndrome affecting more than 150,000 people worldwide. The majority of patients develop FMF before the age of 20. FMF may cause amyloidosis, which mainly affects the kidneys but may also be accumulated in other organs such as the heart, gastrointestinal tract, and reproductive organs. FMF being a systemic disorder with a risk for amyloidosis, affecting patients in their childbearing years, and with its lifelong colchicine therapy raises concern about its effect on the reproductive system. In this article, we review the impact of FMF and its treatment to the reproductive system of male and female patients, pregnancy, and lactation.
家族性地中海热(FMF)是一种常染色体隐性疾病,其特征为发热、腹膜炎、胸膜炎、关节炎或丹毒样皮肤病变反复发作。FMF是最常见的周期性发热综合征,全球有超过15万人受其影响。大多数患者在20岁之前发病。FMF可能导致淀粉样变性,主要影响肾脏,但也可能在心脏、胃肠道和生殖器官等其他器官中积聚。FMF是一种全身性疾病,有发生淀粉样变性的风险,影响育龄期患者,且需要终身服用秋水仙碱治疗,这引发了人们对其对生殖系统影响的担忧。在本文中,我们综述了FMF及其治疗对男性和女性患者生殖系统、妊娠及哺乳的影响。